Abiopharma

NASDAQ traded attribute type Security_Name was changed. Previous value: COSCIENS Biopharma Inc. - Common Stock. New value: COSCIENS Biopharma Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: ImmunoPrecise Antibodies Ltd. - Common Stock. New value: ImmunoPrecise Antibodies Ltd. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: COSCIENS Biopharma Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: D. New value: Portage Biotech Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: ImmunoPrecise Antibodies Ltd. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Portage Biotech Inc. - Common Stock. New value: Portage Biotech Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Portage Biotech Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: COSCIENS Biopharma Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: ImmunoPrecise Antibodies Ltd. - Common Stock.

Decheng Capital China Life Sciences USD Fund III, L.P. 🔴 sold 4.9K shares of BeyondSpring Inc. (BYSI) at $1.81 Transaction Date: Aug 29, 2025 | Filing ID: 023607

Proposed issue of securities - MSB

Familiar Calderon Gerardo 🔴 sold 1.3K shares of Chemours Co (CC) at $15.40 Transaction Date: Sep 01, 2025 | Filing ID: 112928

Mesoblast Option to Issue up to US$50m Convertible Notes

New Form SCHEDULE 13D/A - vTv Therapeutics Inc. Filed: 2025-09-03 AccNo: 0001415889-25-023605 Size: 18 KB

Edgewise Therapeutics - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules